Baseline And Early Change Of Systemic Inflammation Index (Bsii And Delta Sii) As Prognostic Factors In Metastatic Renal Cell Carcinoma (Mrcc) Patients Treated With Nivolumab: Final Results Of The Meet-Uro 15 (I-Bio-Rec) Study.
JOURNAL OF CLINICAL ONCOLOGY（2020）
摘要
5072Background: Biomarkers to select mRCC patients most likely to benefit to immunotherapy are still needed. The retrospective multicentre Meet-URO-15 study evaluated the prognostic role of periphe...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要